skip to main content
Newsroom
Overview   News
Pilot coordinated assessment for clinical investigations and performance studies (CI/PS): call for applications

Pilot coordinated assessment for clinical investigations and performance studies (CI/PS): call for applications

In February 2025, the European Commission launched a call for applications for expression of interest to participate in an EU pilot coordinated assessment of clinical investigations (CI) and performance studies (PS) across multiple Member States as per Articles 78 of Regulation (EU) 2017/745 on medical devices (MDR) and 74 of Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR), respectively.

The call is open until 30 June 2025.

For more, see the Commission’s web page on Clinical investigations and performance studies.

 
EMA regular procedure for scientific advice on certain high-risk medical devices

EMA regular procedure for scientific advice on certain high-risk medical devices

In February 2025, the European Medicines Agency (EMA) announced the establishment of a regular procedure for manufacturers to request scientific advice on the intended clinical development strategy for certain high-risk medical devices.

The advice procedure is available for two types of medical devices: class III devices: invasive and sustain or support human life; class IIb active devices: intended to administer or remove medicines.

 
Latest meetings of the Medical Device Coordination Group (MDCG)

Latest meetings of the Medical Device Coordination Group (MDCG)

The latest meetings of the Medical Device Coordination Group (MDCG) took place in December 2024 and in February 2025 with national competent authorities, including sessions with the sectorial stakeholders.

For more, see the information on the MDCG meetingon 17 to 18 December 2024, the meeting between the MDCG and stakeholderson 17 December 2024, the MDCG meeting on 18 to 19 February 2025 and the meeting between the MDCG and stakeholders on 18 February 2025 from the Register of Commission Expert Groups and Other Similar Entities.

The list of 2025 planned meetings of MDCG and Subgroupsis available from the Commission’s web page on Medical Device Coordination Group Working Groups.

 
Advice on SARS-CoV-2 on request from the Medical Device Coordination Group

Advice on SARS-CoV-2 on request from the Medical Device Coordination Group

In January 2025, the in vitro diagnostic medical devices (IVD) expert panel, on request from the Medical Device Coordination Group (MDCG), provided new scientific advice on SARS-CoV-2. This information may affect how SARS-CoV-2 tests are classified under Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR).

For more, see the Commission’s web page on Expert panels.

 
Updated notified bodies survey on certifications and applications (MDR/IVDR)

Updated notified bodies survey on certifications and applications (MDR/IVDR)

In October 2024, the European Commission issued the latest update of the notified bodies (NB) survey on certifications and applications under Regulations (EU) 2017/745 on medical devices (MDR) and (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). It contains the results of the 10th NB survey with data status 30 June 2024 (small and medium dataset).

For more, see the Commission’s web page on Notified bodies.

 
Revised MDCG 2022-5 on ‘Guidance on borderline between medical devices and medicinal products under Regulation (EU) 2017/745 on medical devices’

Revised MDCG 2022-5 on ‘Guidance on borderline between medical devices and medicinal products under Regulation (EU) 2017/745 on medical devices’

In October 2024, the Medical Device Coordination Group (MDCG) endorsed the revised version of the document MDCG 2022-5 rev.1 providing guidance on the borderline between medical devices and medicinal products under Regulation (EU) 2017/745 on medical devices (MDR).

For more, see the Commission’s web page on Guidance.

 
New MDCG 2024-14 on ‘Guidance on the implementation of the Master UDI-DI solution for contact lenses’

New MDCG 2024-14 on ‘Guidance on the implementation of the Master UDI-DI solution for contact lenses’

In November 2024, the Medical Device Coordination Group (MDCG) endorsed the new document MDCG 2024-14 providing guidance on the implementation of the ‘Master UDI-DI’ solution for contact lenses, as introduced by Commission Delegated Regulation (EU) 2023/2197.

For more, see the Commission’s web page on Guidance.

 
New Q & A on the gradual roll-out of Eudamed

New Q & A on the gradual roll-out of Eudamed

In November 2024, the European Commission issued a new question and answers (Q & A) document on practical aspects related to the implementation of the gradual roll-out of the European database on medical devices (Eudamed) pursuant to Regulations (EU) 2017/745 on medical devices (MDR) and (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) as amended by Regulation (EU) 2024/1860.

For more, see the Commission’s web page on Guidance.

 
New MDCG 2024-15 on ‘Guidance on the publication of the clinical investigation reports and their summaries in the absence of Eudamed’

New MDCG 2024-15 on ‘Guidance on the publication of the clinical investigation reports and their summaries in the absence of Eudamed’

In November 2024, the Medical Device Coordination Group (MDCG) endorsed the new document MDCG 2024-15 providing guidance on the publication of the clinical investigation reports and their summaries in the absence of the European database on medical devices (Eudamed).

For more, see the Commission’s web page on Guidance.

 
Revised MDCG 2019-13 on ‘Guidance on sampling of devices for the assessment of the technical documentation’

Revised MDCG 2019-13 on ‘Guidance on sampling of devices for the assessment of the technical documentation’

In December 2024, the Medical Device Coordination Group (MDCG) endorsed the revised version of the document MDCG 2019-13 rev.1 providing guidance on sampling of devices for the assessment of the technical documentation.

For more, see the Commission’s web page on Guidance.

 
New MDCG 2024-16 on ‘Manufacturer Information Form on Interruption or Discontinuation of Supply of certain medical devices and certain in vitro diagnostic medical devices’

New MDCG 2024-16 on ‘Manufacturer Information Form on Interruption or Discontinuation of Supply of certain medical devices and certain in vitro diagnostic medical devices’

In December 2024, the Medical Device Coordination Group (MDCG) endorsed the new document MDCG 2024-16, providing the ‘Manufacturer Information Form’ on the interruption or discontinuation of supply of certain devices. It also includes an Annex with the ‘Device Identification Table’.

For more, see the Commission’s web page on Guidance.

 
Revised Q & A on ‘Obligation to inform in case of interruption or discontinuation of supply’

Revised Q & A on ‘Obligation to inform in case of interruption or discontinuation of supply’

In December 2024, the European Commission revised the question and answers (Q & A) document on practical aspects related to the implementation of the obligations to inform in case of interruption or discontinuation of supply of certain deviceslaid down in the new Articles 10a of Regulations (EU) 2017/745 on medical devices (MDR) and (EU) 2017/746 on in vitro diagnostic medical devices (IVDR).

For more, see the Commission’s web page on Guidance.

 
Revised MDCG 2023-3 on ‘Questions and Answers on vigilance terms and concepts as outlined in Regulation (EU) 2017/745 and Regulation (EU) 2017/746’

Revised MDCG 2023-3 on ‘Questions and Answers on vigilance terms and concepts as outlined in Regulation (EU) 2017/745 and Regulation (EU) 2017/746’

In January 2025, the Medical Device Coordination Group (MDCG) endorsed a new revised version of the document MDCG 2023-3 rev.2 on questions and answers on vigilance terms and concepts as outlined in Regulations (EU) 2017/745 on medical devices (MDR) and (EU) 2017/746 on in vitro diagnostic medical devices (IVDR).

For more, see the Commission’s web page on Guidance.